Literature DB >> 31574421

New psychoactive substances: An actual problem or an overestimated phenomenon?

Fabio Vaiano1, Jennifer P Pascali2, Elisabetta Bertol3.   

Abstract

In last years, international and national Institutions have been completely focused on the new psychoactive substances (NPS) phenomenon. Many contrast policies have been planned in order to control their spread. Even scientific entities, such as our Forensic Toxicology Division, have spent time and resources for NPS identification in biological (from clinical and forensic caseworks) and non-biological (seized material) samples. Last reports show a low prevalence of NPS across the Europe and Italy, while the classical drugs are still the main cause of drug-related deaths. In particular, a worrisome datum is represented by the increasing number of deaths due to heroin. Seen these statistics, is the NPS phenomenon overestimated? Is the interest in classical drugs decreased? Were we diverted by NPS?
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drugs of abuse; Forensic toxicology; Law enforcement agencies; New psychoactive substances

Mesh:

Substances:

Year:  2019        PMID: 31574421     DOI: 10.1016/j.forsciint.2019.109941

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  Methiopropamine and its acute behavioral effects in mice: is there a gray zone in new psychoactive substances users?

Authors:  Fabio De-Giorgio; Sabrine Bilel; Micaela Tirri; Raffaella Arfè; Claudio Trapella; Cristian Camuto; Federica Foti; Paolo Frisoni; Margherita Neri; Francesco Botrè; Matteo Marti
Journal:  Int J Legal Med       Date:  2020-05-01       Impact factor: 2.686

2.  Intoxication by 3-MeO-PCP and O-desmethyltramadol: an unusual NPS mix.

Authors:  André Lobo Castro; Maria José C S Pinto da Costa; Sónia Tarelho; Lara Sousa; Fernando Russo; João Miguel Franco
Journal:  Int J Legal Med       Date:  2022-04-01       Impact factor: 2.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.